Current real-world treatment patterns and outcomes in patients with relapsed/refractory multiple myeloma.

被引：0
|
作者：
Willson, Jenny
Bruno, Amanda
Opalinska, Joanna
Nelson, Jeanenne Joy
Lunacsek, Orsolya
Stafkey-Mailey, Dana
Willey, Joanne P.
机构：
[1] GSK, London, England
[2] GlaxoSmithKline, Collegeville, PA USA
[3] GlaxoSmithKline, Res Triangle Pk, NC USA
[4] Xcenda, Palm Harbor, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e20038
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20038
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Current Real-World Treatment Patterns and Outcomes in Patients with Relapsed/Refractory Multiple Myeloma
    Willson, Jenny
    Bruno, Amanda
    Opalinska, Joanna
    Nelson, Jeannene
    Lunacsek, Orsolya
    Stafkey-Mailey, Dana
    Willey, Joanne
    [J]. BLOOD, 2018, 132
  • [2] Recent real-world treatment patterns and outcomes in US patients with relapsed/refractory multiple myeloma
    Bruno, Amanda S.
    Willson, Jenny L.
    Opalinska, Joanna M.
    Nelson, Jeanenne J.
    Lunacsek, Orsolya E.
    Stafkey-Mailey, Dana R.
    Willey, Joanne P.
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2020, 13 (09) : 1017 - 1025
  • [3] Real-World Outcomes with Panobinostat in Patients with Relapsed/Refractory Multiple Myeloma
    Biran, Noa
    Vesole, David H.
    Zhang, Shijia
    Richter, Joshua R.
    Kuo, Yen-Hong
    Schmidt, Linda
    McBride, Laura
    Anand, Palka
    Ivanovski, Kristin
    Pierre, Amy
    Kumka, Susan
    Cuccurullo, Carmela
    Siegel, David S.
    [J]. BLOOD, 2016, 128 (22)
  • [4] Real-World Practice Patterns with Carfilzomib in Patients with Relapsed and Refractory Multiple Myeloma
    Harvey, R. Donald
    Cong, Ze
    Werther, Winifred
    Lethen, Jan L.
    Lonial, Sagar
    [J]. BLOOD, 2014, 124 (21)
  • [5] Real-world treatment patterns and outcomes in lenalidomide refractory multiple myeloma patients in Europe: a real-world survey
    Martinez-Lopez, Joaquin
    Mendes, Joao
    Luke, Emily
    Kluth, Caspian
    Salmon, Phoebe
    Bailey, Abigail
    Ribbands, Amanda
    Gay, Francesca
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S198 - S199
  • [6] Real-World Treatment of Patients With Relapsed/Refractory Myeloma
    Ntanasis-Stathopoulos, Ioannis
    Gavriatopoulou, Maria
    Terpos, Evangelos
    Dimopoulos, Meletios A.
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (06): : 379 - 385
  • [7] Real-world treatment patterns in relapsed/refractory multiple myeloma: Clinical and economic outcomes in patients treated with pomalidomide or daratumumab
    Richter, Joshua
    Anupindi, Vamshi Ruthwik
    Yeaw, Jason
    Kudaravalli, Suneel
    Zavisic, Stojan
    Shah, Drishti
    [J]. JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (02) : 395 - 409
  • [8] REAL-WORLD BORTEZOMIB USAGE PATTERNS AMONG PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
    Calkins, G.
    Kohansimeh, J.
    Krishna, A.
    Green, R. J.
    Curtis, M.
    Lindberg, F. P.
    Jaskiw, A.
    Larrabee, K.
    Terry, M.
    Feinstein, R. N.
    Plotkin, L.
    Palladino, M. L.
    Nicacio, L. Viana
    [J]. HAEMATOLOGICA, 2015, 100 : 742 - 742
  • [9] Real-world assessment of treatment patterns and outcomes in patients with lenalidomide-refractory relapsed multiple myeloma from the Flatiron database
    Dhakal, Binod
    Einsele, Hermann
    Schecter, Jordan
    Deraedt, William
    Lendvai, Nikoletta
    Slaughter, Ana
    Lonardi, Carolina
    Nair, Sandhya
    He, Jianming
    Voelker, Jennifer
    Cost, Patricia
    Valluri, Satish
    Pacaud, Lida
    Yalniz, Fevzi
    Yong, Kwee
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S168 - S168
  • [10] Real-World Treatment Patterns, Time to Next Treatment, and Economic Outcomes in Relapsed or Refractory Multiple Myeloma Patients Treated with Pomalidomide or Carfilzomib
    Chen, Chi-Chang
    Parikh, Kejal
    Abouzaid, Safiya
    Purnomo, Lea
    McGuiness, Catherine B.
    Hussein, Mohamed
    Wade, Rolin L.
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2017, 23 (02): : 236 - 236
12345